CRDF NASDAQ
Cardiff Oncology, Inc.
1W: -9.7%
1M: +5.7%
3M: -13.8%
YTD: -57.9%
1Y: -46.1%
3Y: -30.0%
5Y: -84.8%
$1.12
-0.06 (-5.08%)
Weekly Expected Move ±11.0%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-11-18
Earliest Filing
2021-11-18
Latest Filing
investor: 1
Counterparties (Filed by CRDF)
1 relationshipsCompanies named in CRDF's SEC 8-K filings as business counterparties.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-14 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-07-16 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-06-11 | Shareholder Vote | View | |
| 2026-06-03 | Regulation FD | View | |
| 2026-05-29 | Material Agreement | Agreement | View |
| 2026-05-19 | Other Events | View | |
| 2026-04-09 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-04-02 | Material Agreement; Officer/Director Change | Agreement | View |
| 2026-02-25 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-24 | Completion of Acquisition or Disposition of Assets; Financial Statements and Exhibits | Acquisition | View |
| 2026-01-27 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-29 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events | View | |
| 2025-06-26 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-17 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-06 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2024-12-10 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR